Abstract. We demonstrate that Tc45, a polypeptide described as an immunogenetically restricted Trypanosoma cruzi antigen in mice, is calreticulin, a dimorphic molecule encoded by genes with variable chromosomal distribution. Previously we showed that IgG from A.SW (H2 s ) mice immunized with T. cruzi trypomastigotes or epimastigotes and sera from infected humans recognize Tc45, a 45 kD parasite polypeptide. Herein we describe the cloning, sequencing, and expression of the Tc45 gene. A 98% homology in the deduced amino acid sequence was found with a T. cruzi calreticulin-like molecule and 41% with Leishmania donovani and human calreticulin. In the T. cruzi CL Brener clone and in the Tulahuén strain, the gene is located in two and four chromosomes, respectively. Calreticulin was detected in several T. cruzi clones, in the Tulahuén strain, and in T. rangeli, displaying alternative 43 and 46 kD forms.
INTRODUCTION
Trypanosoma cruzi, an obligate intracellular parasite, is the causal agent of Chagas' disease. Close to 20 million people are infected with the parasite in Latin America. To date, about 90 T. cruzi antigens have been biochemically characterized and about 30% of their coding genes have been cloned, sequenced, and expressed. [1] [2] [3] [4] [5] [6] Although important contributions have been made to better define their potential role as immunogens or diagnostic tools, no functional characterization has been defined for the majority of the described parasite molecules. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The immunological functions of calreticulin in mammals have been delineated to some extent, in particular as a chaperone molecule in the process of antigen presentation to CD8ϩ T cells. Thus, when ␤ 2 -microglobulin binds to the major histocompatibility complex (MHC) class I ␣ chain, the partially folded ␣␤ 2 -microglobulin heterodimer dissociates from calnexin and binds calreticulin. [14] [15] [16] The findings previously reported by this laboratory, 7, 17, 18 have characterized the immunogenicity and diagnostic value of T. cruzi calreticulin, then known as Tc45. These results plus those reported here open a wide range of possibilities to study the role of this immunologically relevant molecule in parasite infectivity and its potential immunoprophylactic and immunodiagnostic value.
Although the immune response to a variety of simple antigens is controlled by genes located in the H2 region, 19, 20 the response against complex organisms such as the intracellular parasite T. cruzi is probably controlled by multiple genes in the host genome, including the MHC. In the murine model, the A.SW (H2 s ) and A.CA (H2 f ) congenic strains differ in their sensitivity to an acute infection with blood trypomastigotes of the T. cruzi Tulahuén strain. 21 A.SW mice survive indefinitely, while A.CA mice die about 15 days post-infection during an acute parasitemia. Passive transfer of purified IgG from immune A.SW animals protects A.CA mice challenged with a lethal dose of parasites. 21 Interestingly, IgG from immune A.SW but not A.CA mice recognized the Tc45 polypeptide. 17, 18 It remains to be determined whether in the murine model the relationship between resistance to acute infection and recognition of Tc45 is causal.
In the context of the human infection, Tc45 is immunogenic in humans infected with T. cruzi. Thus, in immunometric assays 100% variable reactivity with Tc45 was detected in 69 human sera positive for the infection as determined by immunoradiometric and immunowesternblotting (IWB) assays. 7 To contribute to the understanding of the immunogenic and diagnostic values of the T. cruzi antigen Tc45, we present data on the genetic cloning, sequencing, and expression of the encoding gene. We also show data on biochemical characterization of the native Tc45 protein and the chromosome localization of the coding gene. Based on the high homology between the cloned Tc45 DNA sequence reported here and that recently reported for a calreticulin-like molecule in T. cruzi 22 and other calreticulin genes for other species, we propose that Tc45 is indeed T. cruzi calreticulin.
MATERIALS AND METHODS
Parasites. Epimastigotes of cryopreserved T. cruzi clones NR cl3, Nicaragua, SC43 cl2, V86, Esmeraldo cl3, MN cl2, SO3 cl5, P11 cl3, and CL Brener, and also the LDG strain from T. rangeli, were grown in liquid medium. 23 Cultured epimastigotes from the T. cruzi Tulahuén strain were grown in liver infusion tryptose culture medium 24 and harvested at the exponential growth phase.
Parasite antigenic extracts. Parasites were subjected to sonication, 1 mM of N␣-p-tosyl-L-lysine chloromethyl ketone as a protease inhibitor was added, and the material centrifuged and stored at Ϫ70ЊC.
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Monoclonal antibody E2G7 anti-Tc45. This monoclonal antibody (mAb) was generated according to standard procedures 25 with minor modifications. 7 A BALB/c adult female mouse was immunized with Tc45 purified by two independent FPLC chromatographic criteria, ionic exchange, and hydroxylapatite adsorption. This material was recognized by the A.SW but not A.CA congenic strains. 18 The BALB/c mouse received three Tc45 injections, 10 g each, one week apart. The first one (40 L, prepared with equal volumes of saline and Complete Freund Adjuvant) was done in the rear foot pads. The second and third immunizations were administered subcutaneously in the dorsal region and intravenously, respectively. After the second injection, the animal was bled and the presence of anti-Tc45 IgG was verified by IWB. Four days after the last immunization, splenocytes were fused with the BALB/c mouse myeloma subline P3/ x63.Ag8.653. 26 Positive supernatants were monitored by immunoradiometric assay against purified Tc45 and developed with gamma chain-specific polyclonal antibodies. Recognition of Tc45 by positive supernatants was confirmed by IWB against rabbit and murine anti-Tc45 polyclonal antibodies. The mAb was purified from murine ascites by SepharoseProtein G (Sigma, St. Louis, MO). 27 The maintenance and care of experimental animals complied with the National Institutes of Health guidelines for the humane use of laboratory animals.
Electrophoretic dimorphism of Tc45. Protein extracts from T. cruzi and T. rangeli were separated in 10% v/v sodium dodecyl sulfate polyacrylamide gel electrophoresis under reducing conditions. Proteins were transferred onto nitrocellulose filters and Tc45 was detected with the E2G7 mAb followed by an affinity purified and 125 I-labelled heavychain specific anti-mouse goat IgG.
Peptide microsequencing. Briefly, Tc45 was purified by two HPLC criteria, ionic exchange and hydroxylapatite adsorption. The positive fractions monitored by IWB were pooled for further analysis. Sequencing was performed as described. 17, 28 Electroblotted purified Tc45 was stained with Ponceau S, cut out from the nitrocellulose sheet, and destained. The nitrocellulose-bound polypeptide was enzymatically digested in situ with trypsin. Tc45 fragments were separated by reverse phase HPLC. Amino acid sequence analysis was performed on an automated Applied Biosystems model 477A sequencer equipped with on-line phenylthiohydantoin amino acid analyzer, model 120A.
Genetic cloning and expression of Tc45. Isolation of the Tc45 gene was carried out by conventional immunoscreening of a genomic library from Miranda/76 T. cruzi 29 constructed in the bacteriophage gt-11 30 using the E2G7 mAb. Briefly, fusion-protein expression by gt-11-infected Escherichia coli Y-1090 was induced by incubation with nitrocellulose filters soaked in isopropyl thio-␤-D-galactoside (IPTG). Wild-gt-11 phage was used as a negative control. The filters were then blocked, incubated with the E2G7 mAb, washed and developed with ␥-chain specific affinitypurified and radiolabelled rabbit anti-mouse IgG. The filters were then subjected to radioautography. Positive phage plaques were subjected to six further immunoscreenings until 100% plaque positivity was obtained. Protein over-expression was achieved according to standard procedures. 31 Sequencing of the Tc45 coding DNA. Sequencing was performed following PCR amplification of the Tc45 1.6 kb EcoRI insert from the gt-11 isolated clone using forward (5Јd-GGTGGCGACGACTCCTGGAGCCCG-3Ј) and reverse (5Јd-TTGACACCAGACCAA-CTGGTAATG-3Ј) primers (Promega, Madison, WI) flanking the gt-11 insertion site. Amplification products were resolved in low melting point agarose gels, purified (Wizard PCR Preps DNA Purification System, Promega) and sequenced (ds DNA Cycle Sequencing System, Gibco, New York) according to manufacturer's instructions. 32 Internal primers were prepared based on the preliminary sequence until the full sequence of the 1.6 kb EcoRI fragment was obtained.
Chromosome localization of the Tc45 gene. The Tc45 coding DNA sequence was amplified by PCR (using the primers described above) and a radiolabeled probe was ob- tained according to standard procedures. 29 Tulahuén and CL Brener epimastigote chromosomes 33 were separated by Pulse Field Gel Electrophoresis (PFGE) (CHEF DR II Bio-Rad) using standard procedures. [34] [35] [36] The DNA was transferred onto nylon membranes. The Tc45 radioactive DNA probe was hybridized under high stringency conditions and the membrane was exposed to radioautography. 34, 36 Tc45 sequence analysis. Homologies with other described genes were determined by using the BLAST search algorithm at the NCBI Data Base. 37 Signal peptide sequence, cleavage site, molecular weight, isoelectric point, and glycosylation sites were predicted using an artificial neuronal network algorithm available on-line at the Center for Biological Sequences Analysis. 38 T cell epitopes were predicted using the BioInformatics and Molecular Analysis Section (BIMAS) Data Base. 39 
RESULTS
Electrophoretic dimorphism of Tc45. To determine the presence of Tc45 in several T. cruzi clones, the Tulahuén strain and T. rangeli, we used the E2G7 mAb as a probe in IWB. Results of three representative experiments are shown in Figures 1A-C. As shown in Figure 1A -B, a 46 kD form is present in the Nicaragua, Esmeraldo cl3, and SO3 cl5 clones from T. cruzi (Tracks 2, 5, and 8, respectively) and in the LDG strain of T. rangeli (Track 7). An alternative 43 kD electrophoretic form is present in T. cruzi clones NR cl3, SC43 cl2, V86, MN cl2, and P11 cl3 (Tracks 1, 3, 4, 6, and 9, respectively). This dimorphism is more evident in a second experiment where the electrophoresis was extended one hour after the front exit ( Figure 1B) . Tc45 from the Tulahuén strain of T. cruzi displays a 43 kD mobility as shown in a third experiment ( Figure 1C ; Track 2), where the Esmeraldo cl3 (46 kD form, Track 1) and SC43 cl2 (43 kD form, track 3) clones, were used as internal controls.
Cloning, sequencing, and expression of Tc45. To search for structural and functional homologies of Tc45, we cloned its gene, starting from Miranda/76 epimastigote DNA. As shown in Figure 2 , the bacterial lysate containing recombinant Tc45 was subjected to IWB and probed with the antiTc45 E2G7 mAb (in Tracks 3-4, three times more lysate was loaded). Recombinant Tc45 was detected mostly in its free form with a relative molecular mass around 45 kD (most likely because of spontaneous rupture of the peptide bond joining Tc45 with the fusion protein ␤-galactosidase) (Tracks 1 and 3). However, as expected, Tc45 was also detected bound to the fusion ␤-galactosidase protein (about 186 kD for the complex). The 35 kD band, better observed in Track 3, most likely corresponds to a fragment of Tc45, a finding consistent with the high susceptibility to proteolytic digestion (results not shown). As expected, the absence of IPTG prevented the expression of Tc45 (Tracks 2 and 4) . The expression in E. coli confirms the molecular mass observed in the native protein.
The deduced amino acidic sequence of Tc45 is shown in Figure 3 . The gt-11 isolated clone contained an insert of 1,681 bp with an open reading frame of 1,209 bp between nucleotides 2 and 1,210, encoding a 401 amino acid polypeptide. The predicted molecular weight and isoelectric point of the mature polypeptide are 44,506 and 4.80, respectively. 38 A putative signal peptide sequence corresponding to residues 1-20 has been calculated. 38 The sequence displays only one potential O-glycosylation site (amino acid 114). 38 Interestingly, at the amino acid level, 98, 41, and 41% homologies exist with calreticulin from T. cruzi (Tulahuén strain), 7 Leishmania donovani, 40 and humans, 41 respectively. Further analysis of the Tc45 sequence shows a 67% homology with the central region of human calreticulin. Moreover, in the sequence obtained in our laboratory, a full homology was observed with three biochemically microsenquenced peptides (KVYFHEEF, MEHWTTSK, CGGGYIK) obtained from native Tulahuén Tc45. These peptides correspond to positions 22-29, 31-39, and 104-110, respectively.
Chromosome localization of the Tc45 gene. Since differential localization of genes and their subsequent expression may be related with different parasite stages or with infectivity, we attempted to determine the epimastigote chromosomal localization of the gene coding for Tc45/calreticulin using PFGE. As shown in Figure 4 (Tracks 7-8) for the CL Brener clone, the Tc45 gene is located on two different chromosomes (about 1,125 and 2,000 kbp), while in the Tulahuén strain (Tracks 9-10) four different chromosomes bear the relevant sequences (between 1,125-2,000 kbp, approximately). In both, it seems that a third and fifth chromosomes (about 1,700 and 2,400 kbp, respectively) carry a significantly lower number of Tc45 gene copies. All radioactive bands have a corresponding signal in the ethidium bromide-stained gel (Tracks 2-3 and 4-5, respectively).
DISCUSSION
In contrast to the approach used to identify most of the Ags described to date in T. cruzi, Tc45 was first detected by utilizing its immunogenetic restriction in congenic mouse strains. 17, 18 A high affinity mAb (E2G7) against Tc45 allowed us to start the biochemical characterization of this polypeptide. Assays with potential diagnostic value for the human infection have also been developed. 7 Although we have not characterized the biochemical or functional nature of the Tc45 dimorphism shown in Figure  1 , we have determined that it is not altered by treatment with sodium periodate (results not shown). Additionally, since a single potential glycosylation site is present at the amino acid level, post-translational glycosylation seems an unlikely cause for the observed differences in apparent molecular weights among T. cruzi clones, strains, and species ( Figure   1 ). Given the lack of intronic/exonic genomic organization in T. cruzi, alternative mRNA splicing may be ruled out as cause for the observed dimorphism. It remains to be determined if this dimorphism is also present in different stages of the parasite cycle.
When the deduced amino acid sequence of Tc45 is compared with those of calreticulin from T. cruzi, 22 L. donovani, 40 and humans, 41 important homologies are detected. Additionally, if we compare the sequence recently reported for a Tulahuén calreticulin-like molecule 22 with that of the Miranda/76 clone we find discrepancies in only four amino acids (Arg61→Ser, Met129→Val, Asn382→Lys, and Asn388→Val). This is most likely due to strain/clone variations in the sequence of the calreticulin gene. Moreover, in order to confirm that the cloned gene corresponds to the native Tc45, 17, 18 three peptides spanning a total of 23 amino acids obtained from native Tc45 were biochemically microsequenced. Full homologies with the sequences deduced from the Tc45 gene were observed. Finally, Tc45 is about 50% homologous with RAL, a 41 kD calreticulin associated Ag from Litomosoides sigmodontes. 42 Taken together these data support the conclusion that Tc45 is T. cruzi calreticulin.
Although CD8ϩ T cells are crucial in parasite control and survival following infection, few studies have been performed to identify antigens recognized by cytotoxic T cells (CTLs) in T. cruzi. [43] [44] [45] [46] Contingent to its expression in amas- tigotes, calreticulin could be a target for CTLs. In agreement with this possibility, HLA and H2 binding peptide motif searches identify in Tc45 several putative high-affinity T-cell epitopes ( Figure 3) . As an example, for the human HLA-A2 class I molecule, two such epitopes (positions 10-19 and 65-74), and five for the mouse H2K d (positions: 5-13, 24-32, 107-115, 232-240, and 317-325) were identified. 39 Calreticulin has been defined as a high-capacity, calciumand peptide-binding heat-shock protein, 47 interacting with peptides transported into the endoplasmic reticulum by molecules associated with antigen processing. 48 However, its role in T. cruzi seems to be independent from calnexin (whose gene may be absent in T. cruzi genome) and may be associated with glycoprotein folding. 22 Trypanosoma cruzi infection of macrophages seems to inhibit MHC class II 49 but not class I presentation, 45 however, the possibility that T. cruzi calreticulin is able to interact with mammalian class I MHC molecules, modulating the presentation of parasite peptides to CTLs, cannot be ruled out. In this regard, the presence of a signal peptide in the calreticulin sequence 38 favors the possibility that this protein could access the endoplasmic reticulum of the mammalian host cells.
In epimastigotes, most likely a diploid stage in the parasite cycle, 2,35,45,50-52 the results shown in Figure 4 suggest the participation of one and two pairs of homologous chromosomes in the CL Brener clone and Tulahuén strain, respectively. An alternative explanation, valid for the non-cloned Tulahuén strain, is that the four relevant chromosomes correspond to the presence of at least two clones, each one providing one pair of homologous chromosomes. The localization of the calreticulin gene in different chromosomes could be explained by gene transposition or by duplication and translocation. In both CL Brener and Tulahuén parasites, it seems that a third and fifth chromosome carry a significantly lower number of calreticulin gene copies or they may represent cross-hybridizing sequences. Perhaps T. cruzi calreticulin is not an exception in that the majority of genes described thus far have a variable number of tandemly repeated copies per chromosome. 1, 3, 4, 53 Additionally, it is worth noting that the differential expression of these genes could be related with different parasite stages and/or with differences in their infectivity. 
